Long-term activation of protein kinase C by angiotensin II in cultured bovine adrenal medullary cells.
Previous studies from our laboratory suggest that protein kinase C (PKC) is involved in the angiotensin II (AII)-induced increase in the expression of genes encoding proenkephalin and catecholamine biosynthesizing enzymes in primary cultured bovine adrenal medullary (BAM) cells. The purpose of this study was to examine the effects of [Sar1]-AII (S1-AII), an AII agonist, on PKC activity in BAM cells. Thirty-minute incubation with S1-AII produced a dose-dependent activation of PKC. The particulate PKC activity was significantly increased by 2 nM S1-AII after both 30 min and 12 h of incubation. A high concentration of S1-AII (200 nM) caused an increase in particulate PKC activity after 30 min of incubation and this increase was still observed after 18 h of continuous incubation. [Sar1, Thr8]-angiotensin II (S1, T8-AII) (100 microM), an AII antagonist, inhibited the effect of S1-AII (20 nM) on PKC activity, suggesting a specific AII receptor-mediated effect. An increase in BAM cell particulate PKC immunoreactivity after 18 h of S1-AII treatment was observed in Western blot analysis of PKC-immunoreactive protein (82 kDa). The persistent activation of PKC seen in this study is consistent with our hypothesis that PKC may mediate the S1-AII-induced increase in the expression of genes encoding proenkephalin and catecholamine synthesizing enzymes in BAM cells.
Tuominen
R K
RK
Neuropharmacology Section, National Institutes of Health, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.
Hudson
P M
PM
McMillian
M K
MK
Ye
H
H
Stachowiak
M K
MK
Hong
J S
JS
D000313:Adrenal Medulla / Q000166:cytology / Q000201:enzymology*; D000804:Angiotensin II / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D002838:Chromaffin System / Q000166:cytology / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D015151:Immunoblotting; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013997:Time Factors; D014018:Tissue Distribution
D000804:Angiotensin II; C014805:angiotensin II, Sar(1)-Thr(8)-; D011493:Protein Kinase C